Pharmacognosy Magazine

ORIGINAL ARTICLE
Year
: 2020  |  Volume : 16  |  Issue : 67  |  Page : 1--6

Effects of baicalin on pharmacokinetics of florfenicol and mRNA expression of CYP1A2, CYP2C11, CYP3A1, UGT1A1, MDR1, and ABCC2 in rats


Si-Cong Li1, Xu-Ting Li1, Bin Wang1, Rui Yang1, Min Zhang1, Jin-Liang Li1, Wei Huang2, Liang Cao2, Song-Yang Xiao2 
1 Institute of Veterinary Pharmacology, Sichuan Animal Science Academy; Animal Breeding and Genetics Key Laboratory of Sichuan Province, Chengdu, PR China
2 Sichuan Dingjian Animal Pharmaceutical Co., Ltd., Chengdu, PR China

Correspondence Address:
Xu-Ting Li
Institute of Veterinary Pharmacology, Sichuan Animal Science Academy, 7 Niusha Road, Chengdu 610066
PR China

Background: The traditional Chinese medicine Scutellariae radix is often used in combination with antibiotics, such as florfenicol, in Chinese veterinary medicine. Baicalin (5, 6, 7-trihydroxyflavone-7-β-D-glucuronide) is the main active constituent of S. radix. The effects of baicalin on the pharmacokinetics of florfenicol are not known. Thus, we have studied the effects of baicalin on florfenicol pharmacokinetics and the mRNA expression of drug-metabolizing enzymes/efflux transporters in rats. Materials and Methods: Sprague-Dawley rats were given baicalin (50 mg/kg BW or 100 mg/kg BW) or 0.9% sodium chloride solution by intragastric administration for 7 days. They were then fed florfenicol by intragastric administration (25 mg/kg BW) on the 8th day. Blood samples were collected at various times, and the plasma concentrations of florfenicol were estimated with ultra-high performance liquid chromatography. The mRNA expression levels of cytochrome P450 (CYP) CYP1A2, CYP2C11, CYP3A1, UDP-glucuronosyltransferase 1A (UGT1A), multidrug resistance 1, and ATP-binding cassette C2 (ABCC2) in the liver and jejunum were analyzed with a real-time polymerase chain reaction. Results: The area under the concentration-time curve from zero to infinity, mean residence time from zero to infinity, elimination half-life, and peak concentration of florfenicol were significantly increased and the apparent volume of distribution fraction of the dose absorbed and plasma clearance fraction of the dose absorbed were significantly decreased by baicalin; the mRNA expression levels of CYP1A2, CYP2C11, CYP3A1, UGT1A1, and ABCC2 were down-regulated by baicalin. Conclusion: Baicalin affected the pharmacokinetics of florfenicol in rats, increased the plasma concentration and residence time of florfenicol, probably by decreasing the mRNA expression levels of CYP1A2, CYP2C11, CYP3A1, UGT1A1, and ABCC2 in the liver and jejunum.


How to cite this article:
Li SC, Li XT, Wang B, Yang R, Zhang M, Li JL, Huang W, Cao L, Xiao SY. Effects of baicalin on pharmacokinetics of florfenicol and mRNA expression of CYP1A2, CYP2C11, CYP3A1, UGT1A1, MDR1, and ABCC2 in rats.Phcog Mag 2020;16:1-6


How to cite this URL:
Li SC, Li XT, Wang B, Yang R, Zhang M, Li JL, Huang W, Cao L, Xiao SY. Effects of baicalin on pharmacokinetics of florfenicol and mRNA expression of CYP1A2, CYP2C11, CYP3A1, UGT1A1, MDR1, and ABCC2 in rats. Phcog Mag [serial online] 2020 [cited 2020 Feb 20 ];16:1-6
Available from: http://www.phcog.com/article.asp?issn=0973-1296;year=2020;volume=16;issue=67;spage=1;epage=6;aulast=Li;type=0